EPISODE · Apr 12, 2026 · 4 MIN
Tumor - Brain Metastases: Integrating Stereotactic Radiotherapy with Immunotherapy and Targeted Therapy
from Neurosurgery Hub Podcast · host Neurosurgery Hub Team
This episode delves into the critical interplay between advanced systemic therapies and local treatment for brain metastases. Based on the abstract of a study published in Clinical Oncology in 2026, we explore the efficacy and safety of combining stereotactic radiotherapy, specifically using the CyberKnife system, with immunotherapy or targeted therapy in patients with brain metastases from advanced solid cancers. The discussion highlights key findings regarding local control and overall efficacy, providing valuable insights into optimizing treatment strategies for this challenging patient population. Understanding these combined treatment approaches is essential for improving outcomes and managing intracranial disease. This podcast is for informational purposes and does not constitute medical advice.
What this episode covers
This episode delves into the critical interplay between advanced systemic therapies and local treatment for brain metastases. Based on the abstract of a study published in Clinical Oncology in 2026, we explore the efficacy and safety of combining stereotactic radiotherapy, specifically using the CyberKnife system, with immunotherapy or targeted therapy in patients with brain metastases from advanced solid cancers. The discussion highlights key findings regarding local control and overall efficacy, providing valuable insights into optimizing treatment strategies for this challenging patient population. Understanding these combined treatment approaches is essential for improving outcomes and managing intracranial disease. This podcast is for informational purposes and does not constitute medical advice.
NOW PLAYING
Tumor - Brain Metastases: Integrating Stereotactic Radiotherapy with Immunotherapy and Targeted Therapy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m